^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

JS019

i
Other names: JS019, JS 019, JS-019
Associations
Company:
Beijing Eirene, Shanghai Junshi Biosci, Suzhou Kebo Ruijun Bio
Drug class:
CD39 inhibitor
Associations
over2years
New P1 trial
|
ENTPD1 (Ectonucleoside Triphosphate Diphosphohydrolase 1)
|
JS019
over2years
A Phase 1 Study to Evaluate JS019 in Advanced Solid Tumors or Lymphomas (clinicaltrials.gov)
P1, N=172, Recruiting, Suzhou Kebo Ruijun Biotechnology Co., Ltd
New P1 trial
|
ENTPD1 (Ectonucleoside Triphosphate Diphosphohydrolase 1)
|
JS019